VIA
DAWN

Virtus Investment Advisers’s Day One Biopharmaceuticals DAWN Stock Holding History

Virtus Investment Advisers’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Buy
100,990
+19,243
+24% +$271K 0.6% 12
2025
Q4 		$762K Buy
81,747
+15,320
+23% +$128K 0.21% 147
2025
Q3 		$468K Hold
66,427
– – 0.13% 211
2025
Q2 		$432K Buy
66,427
+38,397
+137% +$264K 0.15% 211
2025
Q1 		$222K Buy
+28,030
New +$302K 0.06% 256

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Virtus Investment Advisers's DAWN Position: Q1 2026 in Review

Virtus Investment Advisers increased its Day One Biopharmaceuticals (DAWN) stake by 24% in Q1 2026, buying an estimated $271K and bringing the position to 100,990 shares worth $2.17M. The position accounts for 0.6% of the portfolio, ranked #12.

Virtus Investment Advisers first reported a position in DAWN in Q1 2025 and has held it in 5 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Virtus Investment Advisers held 100,990 shares of Day One Biopharmaceuticals worth $2.17M as of Q1 2026.
  • Virtus Investment Advisers bought 19,243 Day One Biopharmaceuticals shares in Q1 2026, an estimated $271K.
  • Day One Biopharmaceuticals made up 0.6% of Virtus Investment Advisers's portfolio in Q1 2026, its #12 holding.
  • Virtus Investment Advisers first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.